Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probe. (Record no. 19202723)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01664 a2200457 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515191009.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201009s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1873-4294 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.2174/156802609789753635 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Weaver, C David |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100916 |
245 00 - TITLE STATEMENT | |
Title | Discovery and development of a potent and highly selective small molecule muscarinic acetylcholine receptor subtype I (mAChR 1 or M1) antagonist in vitro and in vivo probe. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Current topics in medicinal chemistry |
Date of publication, distribution, etc. | 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1217-26 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Discovery |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | High-Throughput Screening Assays |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Muscarinic M1 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Substrate Specificity |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | chemical synthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thiadiazoles |
General subdivision | chemical synthesis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sheffler, Douglas J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lewis, L Michelle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bridges, Thomas M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Williams, Richard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nalywajko, Natalia T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kennedy, J Phillip |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mulder, Matthew M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jadhav, Satyawan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aldrich, Leslie A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jones, Carrie K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marlo, Joy E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Niswender, Colleen M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mock, Matthew M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zheng, Fang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Conn, P Jeffrey |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lindsley, Craig W |
773 0# - HOST ITEM ENTRY | |
Title | Current topics in medicinal chemistry |
Related parts | vol. 9 |
-- | no. 13 |
-- | p. 1217-26 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.2174/156802609789753635">https://doi.org/10.2174/156802609789753635</a> |
Public note | Available from publisher's website |
No items available.